BMRN Financial Facts

Weighted average common shares outstanding, basic: 147.02M
NET INCOME (LOSS) PER SHARE, BASIC: 0.05
See Full Income Statement

Other current assets: 56.46M
Accumulated other comprehensive income (loss): 19.19M
See Full Balance Sheet

BioMarin Pharmaceutical Inc. (BMRN) Earnings

  |   Expand Research on BMRN
Next EPS Date 4/17/15 *Est. EPS Growth Rate -327.3% *Last Qtr.
Average EPS % Beat Rate +40.0% Revenue Growth Rate +57.2% *Last Qtr.
Average % Move 1-Wk after EPS +3.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/21/13 Q412 -$0.43-$0.27 -$0.16$130.96M$129.7M = Details
2/16/12 Q411 -$0.23-$0.11 -$0.12$107.9M$115.3M = Details
10/24/13 Q313 -$0.38-$0.30 -$0.08$136.9M$140M = Details
4/26/12 Q112 -$0.21-$0.14 -$0.07$116.6M$119.24M = Details
8/1/12 Q212 -$0.27-$0.21 -$0.06$124M$121.54M = Details
4/25/13 Q113 -$0.31-$0.29 -$0.02N/A$131.44M = Details
7/28/11 Q211 -$0.05-$0.11 +$0.06$110.63M$105.9M Details
10/23/14 Q314 -$0.16-$0.22 +$0.06$176.8M$206M N/A Details